IVF Financing Math: Shared-Risk Refund Program vs. $28K Loan vs. Credit Card at 12%, 25%, and 40% Odds Per Cycle
You've just been handed a financing packet. Maybe it's after a cycle that didn't work, maybe it's before your first. Either way, you're looking at three options: a shared-risk refund program, a loan, or a payment plan. They all sound reasonable until you try to compare them. Then you find out the comparison depends on a number the clinic can't give you: your own odds per cycle.
If you're doing this math after a failed cycle, I'm sorry. Being asked to run a spreadsheet while you're grieving is a lot. This post builds one worked example with a $28,000 all-in cycle and runs it at three different per-cycle success rates. It also shows how to find the maximum fee a refund program should charge before paying per cycle is the better deal.
One note on the numbers. Everything below is either from the source articles named in the text or from an example I constructed and labeled as an example. The per-cycle success rates are placeholders. They are not SART figures for any clinic, not a prediction for you, and not a treatment recommendation. The point is to show you the structure of the decision so you can plug in your own inputs.
Start with the all-in cost of one cycle
A clinic quote is rarely the whole bill. Here's the example I'll use throughout. Your clinic may bundle some of these lines differently.
| Line item | Example cost |
|---|---|
| Clinic cycle fee | $15,000 |
| PGT-A (embryo genetic testing) | $4,000 |
| Monitoring visits and labs | $1,500 |
| Frozen embryo transfer (FET) | $3,500 |
| Medications | $4,000 |
| All-in per cycle | $28,000 |
Of that, $24,000 is clinic-side and $4,000 is medications. That split matters because refund programs often exclude meds. For the line-by-line version, see our IVF cycle cost breakdown.
Your per-cycle odds change everything
Every financing option is really a bet on how many cycles you'll need. To compare them, you need a per-cycle live birth probability for someone like you, meaning your age band and diagnosis. SART publishes clinic-level data, but it's hard to read for your situation. We walk through that in how to read SART clinic data by age.
For this example I'm using three placeholder per-cycle rates: 12%, 25%, and 40%. The cumulative chance of at least one live birth across three cycles is 1 − (1 − p)³:
| Per-cycle odds (p) | After 1 cycle | After 2 cycles | After 3 cycles |
|---|---|---|---|
| 40% | 40.0% | 64.0% | 78.4% |
| 25% | 25.0% | 43.8% | 57.8% |
| 12% | 12.0% | 22.6% | 31.9% |
This treats each cycle as independent, which real life doesn't. A poor response in cycle one tells you something about cycle two. Treat these as a first-pass model, not a forecast.
Option 1: Pay per cycle
With pay-per-cycle you spend $28,000 and stop when you have a live birth, or after three cycles in this example. The expected number of cycles is 1 + (1 − p) + (1 − p)².
| Per-cycle odds | Expected cycles | Expected spend | Worst case (3 failures) |
|---|---|---|---|
| 40% | 1.96 | $54,880 | $84,000 |
| 25% | 2.31 | $64,750 | $84,000 |
| 12% | 2.65 | $74,323 | $84,000 |
There's a shortcut here. Expected spend per live birth works out to the cycle cost divided by the per-cycle odds. That's $28,000 ÷ 0.40 = $70,000 at 40%, $112,000 at 25%, and about $233,000 at 12%. These are expected averages across everyone who tries, including people who never reach a birth, so they're not a bill anyone receives. They are the reason two clinics with a $500 difference in sticker price can differ by tens of thousands per baby. Your age band's number is the one that counts, not the national average.
Option 2: The shared-risk refund program
Shared-risk (refund) programs charge a higher upfront fee for a bundle of cycles, then refund some or all of it if you don't have a live birth. Terms vary a lot by clinic. For the example I'm assuming:
- $58,000 upfront for up to 3 cycles, including transfers
- 80% refund ($46,400) if there's no live birth after the bundle
- Medications not included ($4,000 per cycle you actually do)
Here's how that plays out in four scenarios:
| What happens | Shared-risk total | Pay-per-cycle total | Difference |
|---|---|---|---|
| Live birth on cycle 1 | $62,000 | $28,000 | +$34,000 |
| Live birth on cycle 2 | $66,000 | $56,000 | +$10,000 |
| Live birth on cycle 3 | $70,000 | $84,000 | −$14,000 |
| No live birth after 3 cycles | $23,600 | $84,000 | −$60,400 |
That first row is what I call the lucky penalty. If your first cycle works, you've overpaid by $34,000 for insurance you didn't need. The last row is the protection: your worst case drops from $84,000 to $23,600.
Now weight those scenarios by probability. Expected total cost, meds included:
| Per-cycle odds | Pay per cycle | Shared-risk ($58K, 80% refund) | Shared-risk advantage |
|---|---|---|---|
| 40% | $54,880 | $55,818 | −$938 (roughly a wash) |
| 25% | $64,750 | $47,675 | +$17,075 |
| 12% | $74,323 | $36,997 | +$37,326 |
The number to compare against your quote
Don't ask "is shared-risk worth it?" Ask "what's the most I should pay for this program at my odds?" Setting the two expected costs equal gives a break-even fee:
| Per-cycle odds | Break-even program fee (this example's terms) |
|---|---|
| 40% | ≈ $56,900 |
| 25% | ≈ $83,800 |
| 12% | ≈ $140,000 |
If a clinic quotes you $58,000 at 40% odds, you're right at break-even, so the decision is about risk tolerance rather than math. At 25% odds the fee could climb to about $83,800 before pay-per-cycle wins on expected cost.
Don't read the 12% row as "refund programs are great for low odds." Programs generally screen applicants and price accordingly, because a clinic that refunds 80% to patients unlikely to succeed would lose money. The row tells you which fee to hold the clinic to if you're accepted. When you're declined, or quoted a much higher fee, that's information about how the clinic sees your odds.
Break-even is also an expected value, not a guarantee. It ignores how much you value a capped downside, and it ignores fine print. Before you sign, check how the program defines success (live birth versus heartbeat), whether PGT-A and FET are inside the fee, how many transfers count, what voids the refund, and how long the refund takes.
This is the kind of analysis Feralyx runs for you, so you don't have to build the spreadsheet yourself. For a deeper version, see the break-even math after a failed cycle and refund program vs. loan vs. payment plan using your own odds.
Pay now, get paid back later is a cash-flow decision
A recent Healthcare Dive piece, "HRSA discloses manufacturers approved for revised 340B rebate pilot," reports that ten drugmakers will see 21 of their drugs move from upfront discounts to rebates. This isn't about your fertility medications, and I'm not suggesting it changes what you'll pay for them. What it shows is the cash-flow trade in any rebate model. The buyer fronts the full price and waits to be made whole.
A refund program is the same structure with you as the buyer. You front $58,000 and wait for a refund that may or may not come, depending on the outcome and the fine print. The refund also returns principal, not what you paid to carry it. Which brings us to borrowing.
Option 3: Loans, payment plans, and cards
NerdWallet's weekly mortgage rate roundup says rates have found a "new normal above 7%." A mortgage is secured by a house. Unsecured loans for medical care usually don't price lower than that, so treat 7% as closer to a floor than a midpoint. The rates below are illustrative assumptions, not quotes.
| Way to pay $28,000 | Monthly payment | Total paid | Cost of borrowing |
|---|---|---|---|
| Clinic plan, 0% for 12 months (no deferred interest) | $2,333 | $28,000 | $0 |
| Personal loan, 7% APR, 60 months | $554 | $33,268 | ≈ $5,270 |
| Personal loan, 12% APR, 60 months | $623 | $37,370 | ≈ $9,370 |
| Credit card, 22% APR | n/a | n/a | ≈ $513 for each month you carry the balance |
Now stack financing on top of the program fee. Borrowing $58,000 at 12% over 60 months is about $1,290 a month and roughly $19,400 in interest. If the program refunds $46,400 after three failures, that covers part of the principal but none of the interest you paid the lender. If you're comparing a financed refund program with pay-per-cycle on a payment plan, include the interest, because the refund doesn't undo it.
What about a rewards card?
NerdWallet's "Is the New IHG Premium Card Worth Its $350 Fee?" is a hotel-card article, not a fertility one. I'm not reporting its rewards rates. But its logic transfers: whether a fee is worth it depends on your own spending. As a hypothetical, assume a card returns 2% on a $28,000 charge. That's $560, or $210 after a $350 annual fee. You'd need $17,500 in spend at 2% just to cover the fee. Carry that balance at 22% APR for a single month and the interest ($513) wipes out the net reward. Cards can work as a bridge if you pay them off quickly. They're rarely a financing plan. Also ask whether your clinic adds a processing fee for cards.
You can model any of these against your own cycle costs and odds at Feralyx.
Where hospital financial assistance might fit
KFF Health News, in "Hospitals Have a Little-Known Tool To Prevent Medical Debt. Here's How It Works," explains that getting financial assistance from hospitals often means cumbersome forms. Some states now require hospitals to identify and automatically enroll patients who qualify for charity care, which is called presumptive eligibility.
I can't tell you from that article whether fertility treatment qualifies under any hospital's policy. Many financial assistance policies are written around medically necessary care, and elective services may be excluded. Where it may matter is the rest of the bill. If your clinic is hospital-affiliated, or if a complication sends you to a hospital, or if a cycle works and you face prenatal care and delivery, those are hospital bills too. Ask for the written financial assistance policy. Ask which services it covers, and whether your state requires automatic screening. You shouldn't have to fill out a stack of forms to find out.
This also changes your financing math. Every dollar of hospital debt you avoid is a dollar you don't have to borrow against on top of your IVF loan.
Before you paste your numbers into any tool
Healthcare Dive's "Data privacy concerns could hold patients back from using AI" is a reminder that fertility data is among the most sensitive data you have. Your age, AMH, diagnosis, and clinic quotes are exactly what any comparison needs. Before you enter them into a calculator, chatbot, or spreadsheet service, ask where the data is stored, whether it's used to train models, and whether you can delete it. Ask that of us too.
What to ask before you sign anything
- What is the live birth rate per intended retrieval for my age band and diagnosis? Ask for the clinic's SART report and read the cancellation rate alongside it.
- What are the program's acceptance criteria? If I'm declined, what are my options?
- What's excluded from the fee? Ask specifically about medications, PGT-A, FET, and add-ons.
- How is "success" defined, and when is the refund paid?
- What's the all-in out-of-pocket for one cycle and for three? The answer should be a single number, not a list of "starting at" prices. If insurance is in play, see why your benefits portal can't be trusted.
- What interest rate and fees apply if I finance through the clinic's partner?
The takeaway
In this example, the right financing structure shifts with your per-cycle odds. At 40% the refund program is roughly a wash. At 25% you could pay up to about $84,000 and still come out even. At 12% the program's fee should look very different, and so should your acceptance odds. Meanwhile 7%+ borrowing can add $5,000 to $19,000 in interest depending on what you finance.
None of that is knowable from a clinic's brochure. You need your age, your diagnosis, your insurance, your location, and your clinic's own published rates. Before you commit to another cycle, plug your own numbers into Feralyx and compare pay-per-cycle, shared-risk, and financing side by side. A $28,000 decision deserves a calculation built on your inputs rather than a clinic's averages.
Sources
- Hospitals Have a Little-Known Tool To Prevent Medical Debt. Here’s How It Works. — KFF Reproductive Health
- HRSA discloses manufacturers approved for revised 340B rebate pilot — Healthcare Dive
- Data privacy concerns could hold patients back from using AI — Healthcare Dive
- Weekly Mortgage Rates Find a New Normal Above 7% — NerdWallet Health
- Is the New IHG Premium Card Worth Its $350 Fee? — NerdWallet Health